2023
DOI: 10.1021/acsami.3c07188
|View full text |Cite
|
Sign up to set email alerts
|

Modular Drug-Loaded Nanocapsules with Metal Dome Layers as a Platform for Obtaining Synergistic Therapeutic Biological Activities

Arnon Fluksman,
Aritz Lafuente,
Ron Braunstein
et al.

Abstract: Multifunctional drug-loaded polymer–metal nanocapsules have attracted increasing attention in drug delivery due to their multifunctional potential endowed by drug activity and response to physicochemical stimuli. Current chemical synthesis methods of polymer/metal capsules require specific optimization of the different components to produce particles with precise properties, being particularly complex for Janus structures combining polymers and ferromagnetic and highly reactive metals. With the aim to generate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 74 publications
0
1
0
Order By: Relevance
“…Researchers have proposed a wide range of applications of drug-loaded nanoparticles designed to precisely target tumor sites. For instance, glutathione-responsive polyurethane nanoparticles loaded with the DOX drug, developed by Iyer et al, effectively treated xenograft A549 lung tumor models in mice . Additionally, Yang et al recently demonstrated the effectiveness of tumor-specific PEGylated bilirubin nanoparticles loaded with drug dimers, which suppressed robust 4T1 breast cancer cells .…”
Section: Introductionmentioning
confidence: 99%
“…Researchers have proposed a wide range of applications of drug-loaded nanoparticles designed to precisely target tumor sites. For instance, glutathione-responsive polyurethane nanoparticles loaded with the DOX drug, developed by Iyer et al, effectively treated xenograft A549 lung tumor models in mice . Additionally, Yang et al recently demonstrated the effectiveness of tumor-specific PEGylated bilirubin nanoparticles loaded with drug dimers, which suppressed robust 4T1 breast cancer cells .…”
Section: Introductionmentioning
confidence: 99%